Pharmacological inhibition of Src family kinases attenuates hyperuricemic nephropathy
Hyperuricemia is an independent risk factor for chronic kidney disease and contributes to renal fibrosis. This study aims to investigate the effect of Src family kinase (SFK) inhibition on the development of hyperuricemic nephropathy (HN) and the mechanisms involved. In a rat model of HN, feeding ra...
Saved in:
Main Authors: | Chongxiang Xiong (Author), Jin Deng (Author), Xin Wang (Author), Qidi Hou (Author), Shougang Zhuang (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2024-03-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Pharmacologic Targeting of BET Proteins Attenuates Hyperuricemic Nephropathy in Rats
by: Chongxiang Xiong, et al.
Published: (2021) -
Pharmacological and Genetic Inhibition of HDAC4 Alleviates Renal Injury and Fibrosis in Mice
by: Fengchen Shen, et al.
Published: (2022) -
Pharmacological inhibition of SMYD2 protects against cisplatin-induced acute kidney injury in mice
by: Binbin Cui, et al.
Published: (2022) -
Histone Acetylation and Modifiers in Renal Fibrosis
by: Fengchen Shen, et al.
Published: (2022) -
Histone Methyltransferases as Therapeutic Targets for Kidney Diseases
by: Chao Yu, et al.
Published: (2019)